Rejected petition Make Erenumab available to Migraine sufferers on the NHS

Migraine causes loss of vision, speech, numbness, confusion, sickness, fatigue and pain for up to 72 hrs, its more common than diabetes, epilepsy and asthma. 190,000 attacks daily cause 25 million sick days a year. Aimovig halves attacks, NICE rejected it for NHS use. Private cost £480 a month.

More details

Please visit The Migraine Trust website.

This petition was rejected

Why was this petition rejected?

It’s about something that the UK Government or Parliament is not directly responsible for.

We can't accept your petition because this is the responsibility of the National Institute for Health and Care Excellence (NICE), not the UK Government or Parliament.

We only reject petitions that don’t meet the petition standards.

Date submitted 14 January 2019
Get petition data (json format)

About petition data

The data shows the number of people who have signed the petition by country as well as in the constituency of each Member of Parliament. This data is available for all petitions on the site. It is not a list of people who have signed the petition. The only name that is shared on the site is that of the petition creator.